- Home
- Publications
- Publication Search
- Publication Details
Title
Adjuvant Therapy for Stage II Colon Cancer: ASCO Guideline Update
Authors
Keywords
-
Journal
JOURNAL OF CLINICAL ONCOLOGY
Volume -, Issue -, Pages -
Publisher
American Society of Clinical Oncology (ASCO)
Online
2021-12-23
DOI
10.1200/jco.21.02538
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cancer Statistics, 2021
- (2021) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Duration of Adjuvant Doublet Chemotherapy (3 or 6 months) in Patients With High-Risk Stage II Colorectal Cancer
- (2021) Timothy J. Iveson et al. JOURNAL OF CLINICAL ONCOLOGY
- Patient Selection for Adjuvant Chemotherapy in High-Risk Stage II Colon Cancer
- (2020) Chao Zhang et al. AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS
- New Guidelines for optimal patient care with localized colon cancer: recommending what is proven, but also watching what research is bringing.
- (2020) Noelia Tarazona et al. ANNALS OF ONCOLOGY
- Localised Colon Cancer: ESMO Clinical Practice Guidelines for Diagnosis, Treatment and Follow-up
- (2020) G. Argiles et al. ANNALS OF ONCOLOGY
- Benefit of adjuvant chemotherapy in high-risk colon cancer: A 17-year population-based analysis of 6131 patients with Union for International Cancer Control stage II T4N0M0 colon cancer
- (2020) Andreas Teufel et al. EUROPEAN JOURNAL OF CANCER
- Lymphovascular Invasion and Perineural Invasion Negatively Impact Overall Survival for Stage II Adenocarcinoma of the Colon
- (2019) Matthew Skancke et al. DISEASES OF THE COLON & RECTUM
- Deficient mismatch repair as a prognostic marker in stage II colon cancer patients
- (2019) Ioannis Gkekas et al. EJSO
- Microsatellite Instability and Adjuvant Chemotherapy in Stage II Colon Cancer
- (2019) Julie L. Koenig et al. AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS
- Duration of Oxaliplatin-Containing Adjuvant Therapy for Stage III Colon Cancer: ASCO Clinical Practice Guideline
- (2019) Christopher Lieu et al. JOURNAL OF CLINICAL ONCOLOGY
- Prospective Multicenter Study on the Prognostic and Predictive Impact of Tumor Budding in Stage II Colon Cancer: Results From the SACURA Trial
- (2019) Hideki Ueno et al. JOURNAL OF CLINICAL ONCOLOGY
- Targeted next-generation sequencing of circulating-tumor DNA for tracking minimal residual disease in localized colon cancer
- (2019) N Tarazona et al. ANNALS OF ONCOLOGY
- High-Risk Stage II Colon Cancer: Not All Risks Are Created Equal
- (2018) Blake D. Babcock et al. ANNALS OF SURGICAL ONCOLOGY
- A randomised-controlled trial of 1-year adjuvant chemotherapy with oral tegafur–uracil versus surgery alone in stage II colon cancer: SACURA trial
- (2018) Chu Matsuda et al. EUROPEAN JOURNAL OF CANCER
- Adjuvant chemotherapy for stage II colon cancer: who really needs it
- (2018) Yan Yang et al. Cancer Management and Research
- Administration of adjuvant chemotherapy for stage II-III colon cancer patients: An European population-based study
- (2017) Masoud Babaei et al. INTERNATIONAL JOURNAL OF CANCER
- Patient-Clinician Communication: American Society of Clinical Oncology Consensus Guideline
- (2017) Timothy Gilligan et al. JOURNAL OF CLINICAL ONCOLOGY
- Recommendations for reporting tumor budding in colorectal cancer based on the International Tumor Budding Consensus Conference (ITBCC) 2016
- (2017) Alessandro Lugli et al. MODERN PATHOLOGY
- Combination of primary tumor location and mismatch repair status guides adjuvant chemotherapy in stage II colon cancer
- (2017) Lin Yang et al. Oncotarget
- To Treat or Not to Treat: Adjuvant Therapy for Stage II Colon Cancer in the Era of Precision Oncology
- (2017) Marios Giannakis et al. Journal of Oncology Practice
- Integration of Palliative Care Into Standard Oncology Care: ASCO Clinical Practice Guideline Update Summary
- (2017) Betty R. Ferrell et al. Journal of Oncology Practice
- Systematic review and meta-analysis of the impact of tumour budding in colorectal cancer
- (2016) A C Rogers et al. BRITISH JOURNAL OF CANCER
- Adjuvant chemotherapy is associated with improved survival in patients with stage II colon cancer
- (2016) Leigh Casadaban et al. CANCER
- Effects of Cancer Stage and Treatment Differences on Racial Disparities in Survival From Colon Cancer: A United States Population-Based Study
- (2016) Yinzhi Lai et al. GASTROENTEROLOGY
- Adjuvant chemotherapy is not associated with improved survival for all high-risk factors in stage II colon cancer
- (2016) S.R. Verhoeff et al. INTERNATIONAL JOURNAL OF CANCER
- Updating the American Society of Clinical Oncology Value Framework: Revisions and Reflections in Response to Comments Received
- (2016) Lowell E. Schnipper et al. JOURNAL OF CLINICAL ONCOLOGY
- Efficacy of Adjuvant Chemotherapy in Colon Cancer With Microsatellite Instability: A Large Multicenter AGEO Study
- (2016) David Tougeron et al. JNCI-Journal of the National Cancer Institute
- Efficacy of Adjuvant Chemotherapy in Colon Cancer With Microsatellite Instability: A Large Multicenter AGEO Study
- (2016) David Tougeron et al. JNCI-Journal of the National Cancer Institute
- Defective Mismatch Repair Status was not Associated with DFS and OS in Stage II Colon Cancer Treated with Adjuvant Chemotherapy
- (2015) Jeong Eun Kim et al. ANNALS OF SURGICAL ONCOLOGY
- American Society of Clinical Oncology Statement: A Conceptual Framework to Assess the Value of Cancer Treatment Options
- (2015) Lowell E. Schnipper et al. JOURNAL OF CLINICAL ONCOLOGY
- Risk of recurrence in patients with colon cancer stage II and III: A systematic review and meta-analysis of recent literature
- (2014) Camilla Böckelman et al. ACTA ONCOLOGICA
- Adjuvant chemotherapy use and outcomes of patients with high-risk versus low-risk stage II colon cancer
- (2014) Aalok Kumar et al. CANCER
- Cost Sharing and Adherence to Tyrosine Kinase Inhibitors for Patients With Chronic Myeloid Leukemia
- (2013) Stacie B. Dusetzina et al. JOURNAL OF CLINICAL ONCOLOGY
- Adjuvant Therapy With Fluorouracil and Oxaliplatin in Stage II and Elderly Patients (between ages 70 and 75 years) With Colon Cancer: Subgroup Analyses of the Multicenter International Study of Oxaliplatin, Fluorouracil, and Leucovorin in the Adjuvant Treatment of Colon Cancer Trial
- (2012) Christophe Tournigand et al. JOURNAL OF CLINICAL ONCOLOGY
- Prognostic and Predictive Markers in Stage II Colon Cancer: Is There a Role for Gene Expression Profiling?
- (2011) Robin K. Kelley et al. Clinical Colorectal Cancer
- Value of Mismatch Repair, KRAS, and BRAF Mutations in Predicting Recurrence and Benefits From Chemotherapy in Colorectal Cancer
- (2011) Gordon Hutchins et al. JOURNAL OF CLINICAL ONCOLOGY
- Building better guidelines with BRIDGE-Wiz: development and evaluation of a software assistant to promote clarity, transparency, and implementability
- (2011) Richard N Shiffman et al. JOURNAL OF THE AMERICAN MEDICAL INFORMATICS ASSOCIATION
- Patient and Plan Characteristics Affecting Abandonment of Oral Oncolytic Prescriptions
- (2011) Sonya Blesser Streeter et al. Journal of Oncology Practice
- Does delaying adjuvant chemotherapy after curative surgery for colorectal cancer impair survival? A meta-analysis
- (2010) Gaetan Des Guetz et al. EUROPEAN JOURNAL OF CANCER
- Socio-economic disparities in access to treatment and their impact on colorectal cancer survival
- (2010) C. Lejeune et al. INTERNATIONAL JOURNAL OF EPIDEMIOLOGY
- Defective Mismatch Repair As a Predictive Marker for Lack of Efficacy of Fluorouracil-Based Adjuvant Therapy in Colon Cancer
- (2010) Daniel J. Sargent et al. JOURNAL OF CLINICAL ONCOLOGY
- American Society of Clinical Oncology Guidance Statement: The Cost of Cancer Care
- (2009) Neal J. Meropol et al. JOURNAL OF CLINICAL ONCOLOGY
- Improved Overall Survival With Oxaliplatin, Fluorouracil, and Leucovorin As Adjuvant Treatment in Stage II or III Colon Cancer in the MOSAIC Trial
- (2009) Thierry André et al. JOURNAL OF CLINICAL ONCOLOGY
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started